| Primary Medicine Associates, Llc | |
|
890 N Dean Rd Suite 500 Auburn AL 36830-9440 | |
| (334) 821-2708 | |
| Not Available |
| Full Name | Primary Medicine Associates, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 890 N Dean Rd, Auburn, Alabama |
| Authorized Official Name and Position | Samuel A Price (CFO) |
| Authorized Official Contact | 3345281310 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Primary Medicine Associates, Llc 890 N Dean Rd Suite 500 Auburn AL 36830-9440 Ph: () - | Primary Medicine Associates, Llc 890 N Dean Rd Suite 500 Auburn AL 36830-9440 Ph: (334) 821-2708 |
| NPI Number | 1407099286 |
|---|---|
| Provider Enumeration Date | 04/09/2009 |
| Last Update Date | 05/05/2017 |
| Medicare PECOS PAC ID | 7214089432 |
|---|---|
| Medicare Enrollment ID | O20090720000439 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407099286 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Richard L Horak |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578651287 PECOS PAC ID: 7517988157 Enrollment ID: I20051212000397 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Brian Moffat Wood |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1558473074 PECOS PAC ID: 4385613694 Enrollment ID: I20090728000850 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Michael E Canfield |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1124084785 PECOS PAC ID: 3274428230 Enrollment ID: I20160205001035 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Patricia D Marvets |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750799250 PECOS PAC ID: 4587981048 Enrollment ID: I20200113002637 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Andrew Warren Jones |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1538692553 PECOS PAC ID: 4880968999 Enrollment ID: I20200620000095 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Daniel Barlow |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1457738338 PECOS PAC ID: 3274830708 Enrollment ID: I20200805003321 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Nojan Valadi |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1417171737 PECOS PAC ID: 4082766944 Enrollment ID: I20200916001733 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Samantha Lawson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316592439 PECOS PAC ID: 5991112690 Enrollment ID: I20210324003349 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Amy Merrill |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558726935 PECOS PAC ID: 5698072684 Enrollment ID: I20210520002270 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
| Provider Name | Mallory Willis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1306308309 PECOS PAC ID: 0446588750 Enrollment ID: I20220727002721 |
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
News Archive
Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.
GE Healthcare, Inc. and KC BioMedix, Inc. today announced an agreement that grants GE Healthcare's Maternal Infant Care division exclusive rights for distribution and marketing of the KC BioMedix NTrainer pulsatile neurostimulation system.
American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that the Company has launched a new product called YuYeQingHuo Capsules ("YYQH").
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients-with the potential for individualized therapy to reduce organ rejection and minimize side effects, according to a special article in the April issue of Therapeutic Drug Monitoring, official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
› Verified 7 days ago
Auburn Pediatric And Adult Medicine, L.l.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2353 Bent Creek Rd Ste 110, Auburn, AL 36830 Phone: 334-887-8707 Fax: 334-887-8706 | |
Village Urgent Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1747 Ogletree Rd Ste B, Auburn, AL 36830 Phone: 334-412-2576 | |
East Alabama Campus Health Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Lem Morrison Dr, Auburn, AL 36849 Phone: 334-844-4416 | |
The Oaks Family Healthcare, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2298 E University Dr Ste A-301a, Auburn, AL 36830 Phone: 334-991-5951 | |
Medical Center Plus Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1685 E University Dr Ste E, Auburn, AL 36830 Phone: 334-501-8867 | |
Auburn University Sports Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 349 S Donahue Dr, Auburn, AL 36849 Phone: 334-844-9821 Fax: 334-844-0932 | |
Charles J. Veale, Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2160 Moores Mill Road, Auburn, AL 36830 Phone: 334-826-1704 Fax: 334-826-1787 |